#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13286	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2193	601.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	745	C	695	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25006	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	680.7	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	756	C,T	715,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25006	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	680.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1734	1734	A	777	A,G	734,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25006	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	680.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	813	C	757	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25006	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	680.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2994	2994	T	748	T,C	714,4	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25006	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	680.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	815	A	766	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	V36A	NONSYN	106	108	GTG	415	417	GCG	180;181;180	G;C;G	174;176;174	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	457	459	CGG	170;171;174	C;G;G	162;162;163	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	S68L	NONSYN	202	204	TCG	511	513	TTG	148;147;148	T;T;G	139;139;143	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	A90V	NONSYN	268	270	GCG	577	579	GTT	156;157;155	G;T,G;T	148;140,1;145	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	I105V	NONSYN	313	315	ATT	622	624	GTT	165;164;164	G;T;T	149;143;149	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	N125T	NONSYN	373	375	AAT	682	684	ACC	172;169;170	A;C;C	159;160;158	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	R135C	NONSYN	403	405	CGT	712	714	TGT	180;181;177	T,C;G;T,C	165,1;167;154,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	K151E	NONSYN	451	453	AAA	760	762	GAA	146;146;146	G;A;A	136;137;138	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	763	765	AAC	145;144;145	A;A;C	137;135;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	A172T	NONSYN	514	516	GCG	823	825	ACA	120;120;119	A;C;A	112;115;112	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	A175E	NONSYN	523	525	GCG	832	834	GAA	122;124;124	G;A;A	116;117;119	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	E176T	NONSYN	526	528	GAA	835	837	ACC	127;129;130	A;C;C	117;123;124	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	I178V	NONSYN	532	534	ATC	841	843	GTC	129;131;130	G;T;C	123;123;122	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	I188T	NONSYN	562	564	ATA	871	873	ACG	134;134;131	A;C;G,A	118;120;115,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	P200N	NONSYN	598	600	CCC	907	909	AAC	117;118;119	A;A;C	113;113;115	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	F220L	NONSYN	658	660	TTT	967	969	TTG	128;130;129	T;T;G	120;122;122	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1024	1026	ACC	125;124;124	A;C;C	114;115;114	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1027	1029	GAC	125;125;128	G;A;C	113;114;119	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1036	1038	GCG	124;126;130	G;C;G	115;95;122	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1072	1074	GCT	113;117;117	G;C;T	102;105;106	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1486	folP	858	858	91.61	folP.l6.c17.ctg.1	1587	93.3	1	SNP	p	R230S	1	.	.	688	690	AGC	997	999	AGC	135;138;139	A;G;C	127;129;129	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4730	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3337	141.4	1	SNP	p	S91F	0	.	.	271	273	TCC	549	551	TCC	153;153;153	T;C;C	147;146;147	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4730	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3337	141.4	1	SNP	p	D95G	0	.	.	283	285	GAC	561	563	GAC	155;152;152	G;A;C	147;143;143	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4730	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3337	141.4	1	SNP	p	D95N	0	.	.	283	285	GAC	561	563	GAC	155;152;152	G;A;C	147;143;143	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1564	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1407	110.6	1	SNP	p	G45D	1	.	.	133	135	GAC	511	513	GAC	201;201;199	G;A;C	191;186;191	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	756	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	964	77.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4668	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2877	161.4	1	SNP	p	D86N	0	.	.	256	258	GAC	523	525	GAC	172;173;172	G;A;C	160;161;160	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4668	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2877	161.4	1	SNP	p	S87I	0	.	.	259	261	AGT	526	528	AGT	170;167;169	A;G;T	157;156;156	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4668	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2877	161.4	1	SNP	p	S87R	0	.	.	259	261	AGT	526	528	AGT	170;167;169	A;G;T	157;156;156	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4668	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2877	161.4	1	SNP	p	S87W	0	.	.	259	261	AGT	526	528	AGT	170;167;169	A;G;T	157;156;156	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4668	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2877	161.4	1	SNP	p	S88P	0	.	.	262	264	TCC	529	531	TCC	168;166;164	T;C,G;C	159;156,1;155	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3790	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2695	139.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	170;169;169	G;G;C	164;159;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1281	1283	GCA	207;210;211	G,A,T;C,G;A,C	192,1,1;196,1;200,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1284	1286	ATC	211;213;215	A;T;C,G	199;200;198,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1296	1298	GTG	218;219;219	G,A;T,C;G,C	196,1;194,1;196,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1296	1298	GTG	218;219;219	G,A;T,C;G,C	196,1;194,1;196,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1800	1802	ACC	170;172;173	A;C;C	156;160;162	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1854	1856	GCG	161;161;161	G;C;G	136;124;132	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1854	1856	GCG	161;161;161	G;C;G	136;124;132	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1977	1979	GGC	162;158;157	G;G;C	148;141;143	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1986	1988	GGC	157;156;155	G;G;C	139;140;141	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3526	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2471	142.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2004	2006	CCG	130;130;130	C,G;C;G	102,2;102;102	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5100	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3151	161.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2878	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1762	162.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	550	550	C	197	C	183	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	A249P	NONSYN	745	747	GCT	31	33	CCT	23;23;23	C,G;C;T	0,12;13;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	S271T	NONSYN	811	813	TCG	97	99	ACT	49;49;47	A;C;T	44;47;43	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	103	105	GAT	42;41;38	G;A;T	39;39;37	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	106	108	AGT	38;38;38	A;G;T	37;37;35	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	N277H	NONSYN	829	831	AAC	115	117	CAC	38;38;38	C;A;C	36;37;37	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	R307E	NONSYN	919	921	AGA	205	207	GAA	12;12;12	G;A;A	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	217	219	GCA	13;13;13	G;C;A,T	12;12;12,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	220	222	GAC	13;13;13	G;A;C	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	226	228	ATC	14;14;14	A;T;C	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	232	234	TCG	12;12;12	T;C;G	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	238	240	GCC	12;12;12	G;C;C	12;12;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	241	243	AGC	11;11;11	A;G;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	244	246	GCC	11;11;11	G;C;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	270	91.11	porB1a.l6.c30.ctg.2	302	24.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	250	252	GTT	10;10;11	G;T;T	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	96	95.83	porB1a.l6.c30.ctg.4	269	0.0	0	.	p	.	0	A249P	NONSYN	745	747	GCT	38	40	CCT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	516	300	porB1a	984	96	95.83	porB1a.l6.c30.ctg.4	269	0.0	0	.	p	.	0	G256R	NONSYN	766	768	GGC	59	61	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	G38E	NONSYN	112	114	GGA	491	493	GAA	187;189;189	G;A;A	177;179;181	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	497	499	CAG	189;191;192	C;A;G,C	184;185;186,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	521	523	GGA	206;203;204	G;G;A	196;192;193	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	638	640	GCT	203;202;206	G,A;C;T	188,1;187;188	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	644	646	AGC	209;205;205	A;G;C	195;189;183	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	736	737	CG	206;205	C;G	192;190	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	739	741	CAG	205;207;207	C;A;G	191;196;194	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	743	745	AAA	208;211;212	A;A;A	196;197;197	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	806	808	GAA	207;208;210	G;A,T;A	197;195,1;197	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	830	832	GCA	228;226;228	G;C;A,G	212;212;208,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1013	1015	GAT	196;197;197	G;A;T	182;184;184	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1016	1018	GGT	194;193;189	G;G;T	182;182;175	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1031	1033	ATG	173;174;172	A;T;G	163;166;164	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1145	1147	GCA	207;207;208	G;C;A	196;194;198	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1148	1150	ACG	207;210;209	A;C;G	196;198;197	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1151	1153	GGG	209;208;208	G;G,T;G	200;196,1;196	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1154	1156	GTT	204;206;206	G;T,C;T	194;191,1;196	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1214	1216	GTA	203;200;196	G;T;A	189;185;181	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1253	1255	ACT	205;209;211	A;C;T	193;200;201	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1259	1261	GAT	211;210;208	G;A;T	199;200;200	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1271	1273	CAC	204;205;198	C;A;C,G	195;197;190,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	1	SNP	p	G120K	1	.	.	358	360	AAG	736	738	CGG	206;205;202	C;G;G	192;190;187	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	1	SNP	p	D121N	0	.	.	361	363	GAC	739	742	CGC	205;207;207	C;G;C	191;194;195	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2546	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1564	161.9	1	SNP	p	A121D	1	.	.	361	363	GAC	739	742	CGC	205;207;207	C;G;C	191;194;195	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9288	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4809	192.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1984	1986	CAT	236;236;229	C;A;T	220;220;214	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1002	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1032	96.2	1	SNP	p	V57M	1	.	.	169	171	ATG	549	551	ATG	218;216;217	A;T,C;G,C	206;200,1;202,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
